Micro- and macrovascular function in the highest city in the world: a cross sectional study

[1]  J. Pépin,et al.  Excessive Erythrocytosis and Chronic Mountain Sickness in Dwellers of the Highest City in the World , 2020, Frontiers in Physiology.

[2]  M. Roustit,et al.  Human Skin Microcirculation. , 2020, Comprehensive Physiology.

[3]  C. Lundby,et al.  Re-evaluation of excessive erythrocytosis in diagnosing chronic mountain sickness in men from the world's highest city. , 2020, Blood.

[4]  P. Robach,et al.  Blood viscosity and its determinants in the highest city in the world , 2020, The Journal of physiology.

[5]  P. Dagnelie,et al.  Associations of Arterial Stiffness With Cognitive Performance, and the Role of Microvascular Dysfunction , 2020, Hypertension.

[6]  P. Ainslie,et al.  Global Reach 2018 Heightened α-Adrenergic Signaling Impairs Endothelial Function During Chronic Exposure to Hypobaric Hypoxia , 2020, Circulation research.

[7]  P. Connes,et al.  The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease , 2020, Frontiers in Immunology.

[8]  P. Ainslie,et al.  The impact of hypoxaemia on vascular function in lowlanders and high altitude indigenous populations , 2019, The Journal of physiology.

[9]  P. Ainslie,et al.  GLOBAL REACH 2018: REDUCED FLOW-MEDIATED DILATION STIMULATED BY SUSTAINED INCREASES IN SHEAR STRESS IN HIGH-ALTITUDE EXCESSIVE ERYTHROCYTOSIS. , 2019, American journal of physiology. Heart and circulatory physiology.

[10]  D. Thijssen,et al.  Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. , 2019, European heart journal.

[11]  M. Gassmann,et al.  The increase in hemoglobin concentration with altitude varies among human populations , 2019, Annals of the New York Academy of Sciences.

[12]  M. Roustit,et al.  The continuums of impairment in vascular reactivity across the spectrum of cardiometabolic health: A systematic review and network meta‐analysis , 2019, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[13]  J. Sharman,et al.  Macrovasculature and Microvasculature at the Crossroads Between Type 2 Diabetes Mellitus and Hypertension , 2019, Hypertension.

[14]  P. Ainslie,et al.  Global REACH 2018: High Blood Viscosity and Hemoglobin Concentration Contribute to Reduced Flow-Mediated Dilation in High-Altitude Excessive Erythrocytosis , 2019, Hypertension.

[15]  Christopher J. Marley,et al.  Exaggerated systemic oxidative‐inflammatory‐nitrosative stress in chronic mountain sickness is associated with cognitive decline and depression , 2018, The Journal of physiology.

[16]  V. Pialoux,et al.  Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait , 2018, Diabetes Care.

[17]  G. Parati,et al.  Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders , 2018, High altitude medicine & biology.

[18]  J. Medina-Lezama,et al.  Systemic Hypertension at High Altitude , 2018, Hypertension.

[19]  M. Stembridge,et al.  UBC-Nepal expedition: upper and lower limb conduit artery shear stress and flow-mediated dilation on ascent to 5,050 m in lowlanders and Sherpa. , 2018, American journal of physiology. Heart and circulatory physiology.

[20]  Jackson T. Wright,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.

[21]  W. Strain,et al.  Diabetes, cardiovascular disease and the microcirculation , 2018, Cardiovascular Diabetology.

[22]  M. Burtscher,et al.  Cutaneous Microvascular Blood Flow and Reactivity in Hypoxia , 2018, Front. Physiol..

[23]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[24]  K. Pyke,et al.  Flow-mediated dilation stimulated by sustained increases in shear stress: a useful tool for assessing endothelial function in humans? , 2017, American journal of physiology. Heart and circulatory physiology.

[25]  Walter Calderón-Gerstein,et al.  Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population , 2017, Vascular health and risk management.

[26]  P. Kruzliak,et al.  Inducible nitric oxide synthase: Good or bad? , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  C. Beall,et al.  Antioxidant defense and oxidative damage vary widely among high‐altitude residents , 2017, American journal of human biology : the official journal of the Human Biology Council.

[28]  C. Beall.  Adaptation to High Altitude: Phenotypes and Genotypes , 2014 .

[29]  T. Rusak,et al.  Nitric oxide scavenging by cell-free hemoglobin may be a primary factor determining hypertension in polycythemic patients , 2014, Free radical research.

[30]  C. Sartori,et al.  Oxidative-nitrosative stress and systemic vascular function in highlanders with and without exaggerated hypoxemia. , 2013, Chest.

[31]  C. Beall,et al.  Nitric oxide in adaptation to altitude. , 2012, Free radical biology & medicine.

[32]  Helen Jones,et al.  Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? , 2011, Hypertension.

[33]  Daniel M Tartakovsky,et al.  The effect of small changes in hematocrit on nitric oxide transport in arterioles. , 2011, Antioxidants & redox signaling.

[34]  T. Ogihara,et al.  Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species. , 2009, Journal of molecular and cellular cardiology.

[35]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.

[36]  F. Léon-Velarde,et al.  Consensus statement on chronic and subacute high altitude diseases. , 2005, High altitude medicine & biology.

[37]  C. Suschek,et al.  The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? , 2004, Current molecular medicine.

[38]  R. Korbut,et al.  Nitric oxide and superoxide in inflammation and immune regulation. , 2003, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[39]  K. Nicolaides,et al.  Flow‐mediated dilatation of the brachial artery in pregnancy at high altitude , 2002, BJOG : an international journal of obstetrics and gynaecology.

[40]  S. Thom,et al.  Oscillatory shear stress, flow-mediated dilatation, and circulating microparticles at sea level and high altitude. , 2017, Atherosclerosis.

[41]  C. Sartori,et al.  Systemic vascular dysfunction in patients with chronic mountain sickness. , 2012, Chest.